...
首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.
【24h】

Novel role for vascular endothelial growth factor (VEGF) receptor-1 and its ligand VEGF-B in motor neuron degeneration.

机译:血管内皮生长因子(VEGF)受体1及其配体VEGF-B在运动神经元变性中的新作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Although vascular endothelial growth factor-B (VEGF-B) is a homolog of the angiogenic factor VEGF, it has only minimal angiogenic activity, raising the question of whether this factor has other (more relevant) biological properties. Intrigued by the possibility that VEGF family members affect neuronal cells, we explored whether VEGF-B might have a role in the nervous system. Here, we document that the 60 kDa VEGF-B isoform, VEGF-B(186), is a neuroprotective factor. VEGF-B(186) protected cultured primary motor neurons against degeneration. Mice lacking VEGF-B also developed a more severe form of motor neuron degeneration when intercrossed with mutant SOD1 mice. The in vitro and in vivo effects of VEGF-B(186) were dependent on the tyrosine kinase activities of its receptor, Flt1, in motor neurons. When delivered intracerebroventricularly, VEGF-B(186) prolonged the survival of mutant SOD1 rats. Compared with a similar dose of VEGF, VEGF-B(186) was safer and did not cause vessel growth or blood-brain barrier leakiness. The neuroprotective activity of VEGF-B, in combination with its negligible angiogenic/permeability activity, offers attractive opportunities for the treatment of neurodegenerative diseases.
机译:尽管血管内皮生长因子-B(VEGF-B)是血管生成因子VEGF的同系物,但它的血管生成活性很小,这就提出了该因子是否具有其他(更相关的)生物学特性的问题。对VEGF家族成员影响神经元细胞的可能性感兴趣,我们探讨了VEGF-B是否可能在神经系统中起作用。在这里,我们记录了60 kDa VEGF-B亚型VEGF-B(186)是一种神经保护因子。 VEGF-B(186)保护培养的原代运动神经元免于变性。与突变型SOD1小鼠杂交后,缺乏VEGF-B的小鼠也出现了更严重的运动神经元变性。 VEGF-B(186)的体外和体内作用取决于运动神经元中其受体Flt1的酪氨酸激酶活性。当脑室内递送时,VEGF-B(186)延长了突变型SOD1大鼠的生存期。与相似剂量的VEGF相比,VEGF-B(186)更安全,并且不会引起血管生长或血脑屏障渗漏。 VEGF-B的神经保护活性与其可忽略的血管生成/通透性活性相结合,为治疗神经退行性疾病提供了诱人的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号